Antibacterials/insulin detemir/omeprazole interaction

August 2013
Reactions Weekly;8/1/2013, Issue 1463, p9
The article presents a case study of an 82-year-old man with hypoglycaemia, which developed during treatment with amoxicillin, clarithromycin, omeprazole and insulin detemir for type 2 diabetes.


Related Articles

  • An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea. Barnett, Anthony H.; Dreyer, Manfred; Lange, Peter; Serdarevic-Pehar, Marjana // Diabetes Care;Jun2006, Vol. 29 Issue 6, p1282 

    OBJECTIVE -- To compare the efficacy and safety profile of adding inhaled human insulin (INH; Exubera) or metformin to sulfonylurea monotherapy in patients with poorly controlled type 2 diabetes. RESEARCH DESIGN AND METHODS -- We performed an open-label, parallel, 24-week, multicenter trial. At...

  • Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study. Yang, Jin-Kui; Wang, Lei // Clinical Drug Investigation;2013, Vol. 33 Issue 3, p185 

    Background and Objective: Diabetes mellitus has become a major public health problem in China. This open-label, prospective, multicentre, post-marketing surveillance study was conducted to investigate the efficacy and safety of nateglinide in combination with metformin in Chinese patients with...

  • Glucose-Lowering Effects of Sulfasalazine in Type 2 Diabetes. Haas, Romana M.; Li, Phoebe; Chu, James W. // Diabetes Care;Sep2005, Vol. 28 Issue 9, p2238 

    Presents the case of a 37-year-old woman with systemic lupus erythematosus and type 2 diabetes on high-dose insulin therapy who experienced recurrent severe hypoglycemia after the initiation of sulfasalazine and eventually achieved normoglycemia without the need for diabetes medications. ...

  • HYPOGLYCEMIC AGENTS, ORAL.  // Davis's Drug Guide for Nurses, 10th edition;2007, p616 

    The article presents a nursing guide for several oral hypoglycemic agents, including glimepiride, glipizide, and glyburide, drugs used for controlling blood glucose in patients with non-insulin-dependent diabetes mellitus. The mechanism of action of the drug is discussed. Information on its...

  • Gliclazide interaction.  // Reactions Weekly;8/20/2005, Issue 1065, p11 

    Presents the case of an elderly patient who developed hypoglycaemia coma after receiving gliclazide interaction with cotrimoxazole for type 2 diabetes and urinary tract infection. Dosage of cotrimoxazole administered to the patient.

  • Repaglinide.  // Reactions Weekly;9/5/2009, Issue 1268, p26 

    The article describes the case of an 82-year-old man who experienced hypoglycaemia while receiving repaglinide for type 2 diabetes mellitus. He was presented with confusion and dizziness which appeared 20 minutes prior to arrival. Particular focus is given to the results of laboratory...

  • Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight without Risk of Hypoglycemia in Patients With Type 2 Diabetes. Vilsbøll, Tina; Zdravkovic, Milan; Le-Thi, Tu; Krarup, Thure; Schmitz, Ole; Courrèges, Jean-Pierre; Verhoeven, Robert; Bugánová, Ingrid; Madsbad, Sten // Diabetes Care;Jun2007, Vol. 30 Issue 6, p1608 

    The article presents information on a study conducted to evaluate the efficacy and safety of treatment with liraglutide, a human glucagon-like peptide-1 (GLP-1) analog, in patients with type 2 diabetes. Results showed that the placebo group accounted for almost one-half of the patient...

  • WHEN TO SAY NO TO THIS DRUG. Harrar, Sari; L.T. // Prevention;Aug2002, Vol. 54 Issue 8, p146 

    Reports on the serious and potentially life-threatening side effect, lactic acidosis, that can result from taking metformin, a drug used to treat type 2 diabetes.

  • Liraglutide.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p201 

    The article presents a case study of a 46-year-old woman who experienced acute pancreatitis while treated with liraglutide for her type 2 diabetes mellitus.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics